Metraipolis › archive › dc_68fffbb2ceed

Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study — Europe PMC PMID:42421963

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42421963
DOI: 10.3389/fimmu.2026.1808972
License (as archived): solo-consultazione
Archived: 2026-10-19T04:26:41.905Z
SHA-256 of the archived text: 7fd188ae016195bbff5987884022baec110636040d35830b238c17c32a927312
Stable URL of this page: https://metraipolis.com/documento/dc_68fffbb2ceed

How to cite

Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study — Europe PMC PMID:42421963 — Europe PMC (en), https://europepmc.org/article/MED/42421963 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68fffbb2ceed (Metraipolis archive dc_68fffbb2ceed, sha256 7fd188ae016195bbff5987884022baec110636040d35830b238c17c32a927312)

BibTeX

@misc{dc68fffbb2ceed,
  title = {Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study — Europe PMC PMID:42421963},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42421963},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68fffbb2ceed; sha256 7fd188ae016195bbff5987884022baec110636040d35830b238c17c32a927312},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42421963. Agents can read the archived copy with the MCP tool read_document.